Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRM5 | P41594 | 3/20 | 0.32 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.31 |
| ▸ | SLC22A12 | Q96S37 | 1/20 | 0.30 |
| ▸ | PDE9A | O76083 | 1/20 | 0.30 |
| ▸ | PDE1C | Q14123 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21546649 | 0.91 | ALDH1A3 (0.33) | PTGER4 | |
| SCHEMBL20617034 | 0.91 | RXRA (0.33) | — | |
| SCHEMBL22822131 | 0.90 | CYP1A2 (0.34) | GRM5SLC22A12 | |
| SCHEMBL22822321 | 0.90 | L3MBTL1 (0.34) | GRM5SLC22A12PDE9APDE1C | |
| SCHEMBL19913245 | 0.89 | ALDH1A1 (0.31) | PDE9APDE1C | |
| SCHEMBL22760923 | 0.88 | ELANE (0.34) | — | |
| SCHEMBL22822521 | 0.87 | GRM5 (0.36) | GRM5PTGER4SLC22A12 | |
| SCHEMBL19912442 | 0.87 | AR (0.34) | — | |
| SCHEMBL22822124 | 0.86 | RXRA (0.35) | — | |
| SCHEMBL22760922 | 0.86 | PTGER4 (0.36) | PTGER4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11021473-B2 | Organic molecules for use in organic optoelectronic devices | CYNORA GMBH (DE) | 2021-06-01 | — | — | US | disclosed |
| US-20200399256-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | SAMSUNG DISPLAY CO., LTD. (KR) | 2020-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11021473-B2 | Organic molecules for use in organic optoelectronic devices | OR10J3, OR51E2, OCIAD2 | GRM5 3787/4885PTGER4 1657/4885SLC22A12 1136/4885 |
| US-20200399256-A1 | ORGANIC MOLECULES FOR USE IN ORGANIC OPTOELECTRONIC DEVICES | OR10J3, ORC3, AOC3 | GRM5 3775/4885PTGER4 1529/4885SLC22A12 1829/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.